Current role of liver transplantation for methylmalonic acidemia: A review of the literature

Pediatric Transplantation

Volumn 10, Issue 8, 2006, Pages 943-947

  Kasahara, Mureo ^a,b   Horikawa, Reiko ^a   Tagawa, Manabu ^a   Uemoto, Shinji ^b   Yokoyama, Satoshi ^a   Shibata, Yumiko ^a   Kawano, Takafumi ^a   Kuroda, Tatsuo ^a   Honna, Toshiro ^a   Tanaka, Koichi ^b,c   Saeki, Morihiro ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Liver transplantation; Living donor; Metabolic; Organic acidemia

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLMALONYL COENZYME A MUTASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TSUKUBAENOLIDE;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; BILE LEAKAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HUMAN; INFANT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; METABOLIC ACIDOSIS; METHYLMALONIC ACIDEMIA; MORTALITY; NEUROLOGIC DISEASE; ORGAN DONOR; PANCREATITIS; PREOPERATIVE EVALUATION; RETRANSPLANTATION; SEPSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METABOLISM, INBORN ERRORS; METHYLMALONIC ACID; METHYLMALONYL-COA MUTASE; TREATMENT OUTCOME;

EID: 33750600921     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00585.x     Document Type: Article

References (26)

1. FENTON WA, ROSENBERG Le. Disorders of propionate and methylmalonate metabolism. In: SCRIVER CR, BEAUDET AL, SLY WS, VALLE D, EDS; CHILDS B, KINZLER KW, VOGELSTEIN B, eds. The Metabolic and Molecular Basics of Inherited Diseases. 8th edn. New York: McGraw-Hill, pp. 1423-1449.
2. NAGARAJAN S, ENNS GM, MILLAN MT, WINTER S, SARWAL MM. Management of methylmalonic acidemia by combined liver-kidney transplantation. J Inherit Metab Dis 2005: 28: 517-524.
3. HOSTER F, HOFFMANN GF. Pathophysiology, diagnosis, and treatment of methylmalonic aciduria-recent advances and new challenges. Pediatr Nephrol 2004: 19: 1071-1074.
4. PRIETSCH V, LINDNER M, ZSCHOCKE J, NYHAN WL, HOFFMANN GF. Emergency management of inherited metabolic diseases. J Inherit Metab Dis 2002: 25: 531-546.
5. TODO S, STARZL TE, TZAKIS A, et al. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992: 15: 419-422.
6. LEONARD JV, WALTER JH, MCKIEMAN PJ. The management of organic acidaemias: The role of transplantation. J Inherit Metab Dis 2001: 24: 309-311.
7. VAN'T HOFF W, MCKIEMAN PJ, SURTEES RA, LEONARD JV. Liver transplantation for methylmalonic academia. Eur J Pediatr 1999: 158: S70-74.
8. CHAKRAPANI A, SIVAKUMAR P, MCKIEMAN PJ, LEONARD JV. Metabolic stroke in methylmalonic acidemia five years after liver transplantation. J Pediatr 2002: 140: 261-263.
9. VAN'T HOFF G, DIXON M, TAYLOR J, et al. Combined liver-kidney transplantation in methylmalonic acidemia. J Pediatr 1998: 132: 1043-1044.
10. KAYLER LK, MERION RM, LEE S, SUNG RS, PUNCH JD, RUDISH SM. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002: 6: 295-300.
11. NYHAN WL, GARGUS JJ, BOYLE K, SELBY R, KOCH R. Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. Eur J Pediatr 2002: 161: 377-379.
12. HSUI JY, CHEIN YH, CHU SY, et al. Living-related liver transplantation for methylmalonic acidemia: Report of one case. Acta Paediatr Taiwan 2003: 44: 171-173.
13. HUANG HP, CHIEN YH, HUANG LM, et al. Viral infections and prolonged fever after liver transplantation in young children with inborn errors of metabolism. J Formos Med Assoc 2005: 104: 623-629.
14. SHINKAI M, OHAMA Y. Effect of living donor liver transplantation for methylmalonic academia. Kanagawa Igaku Zasshi 2003: 30: 94.
15. KAPLAN P, MAZUR AM, SMITH R, PALMIERI M, BERRY GT. Transplantation for maple syrup urine disease (MSUD) and methylmalonic acidopathy (MMA). J Inherit Metab Dis 1997: 20(Suppl. 1):37.
16. HO D, HARRISON V, STREET N. Anesthesia for liver transplantation in a patient with methylmalonic acidemia. Paediatr Anaesth 2000: 10: 215-218.
17. GOYENS PH, BRASSEUR D, OTTE JB, et al. Liver transplantation for methylmalonyl-CoA mutase deficiency. J Inherit Metab Dis 1997: 20(Suppl. 1):39.
18. MORIOKA D, KASAHARA M, TAKADA Y, et al. Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant 2005: 5: 2754-2763.
19. MORIOKA D, TAKADA Y, KASAHARA M, et al. Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: Impact of the use of heterozygous donors. Transplantation 2005: 80: 623-628.
20. NICOLAODES P, LEONARD J, SURTEES R. Neurological outcome of methylmalonic acidemia. Arch Dis Child 1998: 78: 508-512.
21. LEONARD J. The management and outcome of propionic and methylmalonic academia. J Inherit Metab Dis 1995: 18: 430-434.
22. OGILER HB, BENOIST JF, RIGAL O, et al. Methylmalonic and propionic acidemias: Management and outcome. J Inherit Metab Dis 2005: 28: 415-423.
23. VANCALCAR SC, HARDING CO, LYNE P, et al. Renal transplantation in a patient with methylmalonic acidemia. J Inherit Metab Dis 1998: 21: 729-737.
24. LUBARNO R, SCOPPI P, BARSOTTI P, et al. Kidney transplantation in a girl with methylmalonic acidemia and end stage renal failure. Pediatr Nephrol 2001: 16: 848-851.
25. KAPLAN P, FICICOGLU C, MAZUR AT, PALMIERI MJ, BERRY GT. Liver transplantation is not curative for methylmalonic acidopathy caused by methylmalonyl-CoA mutase deficiency. Mol Genet Metab 2006 (in press).
26. ANDREWS E, JANSEN R, CRANE AM, CHOLIN S, MCDONNEL D, LEDLEY F. Expression of recombinant human methylmalonyl CoA mutase: In primary mut fibroblasts and Saccharomyces cerevisiae. Biochem Med Metab Biol 1993: 50: 135-144.